Stakeholder Opinions: Endometriosis - Scientific clarity will unlock market potential

Questions: Discounts, Updates etc.

Price: $3,800.00

Publication Date: 2007-12-19

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Endometriosis is a painful, menstrual-related disorder that is thought to affect approximately 10% of the female population of reproductive age. Despite this large patient potential, growth of the endometriosis market has been limited by low levels of investment, poor awareness among physicians and the public, problematic diagnosis, and lack of effective therapies.


Scope

  • Review of treatments and players in the seven major markets including their strategies for success.
  • Movement of patients, depending on their treatment goal, through the referral and the treatment pathway.
  • Overview of the pipeline including coverage of each of the novel mechanisms of action currently being explored.
  • Identification of the unmet need, supported by international opinion leader insight.


    • Report Highlights
    Supporting celebrity spokespeople is a useful strategy for pharmaceutical companies to adopt in the endometriosis market in order to destigmatize the disease and expand the patient population, as witnessed in the erectile dysfunction and osteoporosis markets.

    Imaging techniques, in particular ultrasonography, have the potential to become the new gold-standard diagnostic procedure. Biomolecular and genetic diagnostic tests, to replace CA-125, would be well received by physicians and several are being trialed currently.

    In the current litigious climate and given the return on investment based on the potential patient population, opinion leaders advise that manufacturers of new products would be justified in pursuing a specific endometriosis label.


    Reasons to Purchase

  • Quantify the number of reproductively aged women with endometriosis in the general population and in gynecologic populations in the US, 5EU, and Japan
  • Understand opinion leaders' views on topical issues and unmet need in the endometriosis market.
  • Assess the competitive environment upon launch of a product based on the analysis of key pipeline products and R&D strategies.

    • Table of Contents

    Other users found this report page using the following search terms: endometriosis endometriosis market size visanne prevalence scientific current etiology endometriosis stakeholder

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.